Vimarsana
Biggest News Aggregation in the World

Page 2 - Presentation Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Number Today - Breaking & Trending Today

GV20 Therapeutics Presents Preclinical Data on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024 - Vimarsana News

GV20 Therapeutics Presents Preclinical Data on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024

/PRNewswire/ -- GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody...

Investegate | Company Announcement - Vimarsana News

Investegate | Company Announcement

Investegate announcements from Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update

Huahui Health to Present Preclinical Data of HH018-sesutecan at the 2024 AACR Annual Meeting - Vimarsana News

Huahui Health to Present Preclinical Data of HH018-sesutecan at the 2024 AACR Annual Meeting

/PRNewswire/ -- Huahui Health Ltd.("Huahui Health"), a clinical stage biotechnology company focused on discovering and developing virology, hepatology, and...

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 - Vimarsana News

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15

PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the...

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of ... - Vimarsana News

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of ...

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers